Breaking News Instant updates and real-time market news.

ANAB

AnaptysBio

$78.32

3.15 (4.19%)

06:59
08/07/18
08/07
06:59
08/07/18
06:59

AnaptysBio to deprioritize development of etokimab in peanut allergy

AnaptysBio said in today's earnings release, "As a result of market assessment regarding the adoption of the peanut oral food challenge in future commercial usage of etokimab in peanut allergy patients, AnaptysBio has decided to deprioritize further company-sponsored clinical development of etokimab in moderate-to-severe baseline adult peanut allergy patients. At this time, AnaptysBio does not intend to utilize its clinical development resources to pursue a Phase 2b clinical trial of etokimab in peanut allergy, however the Company may pursue potential investigator-sponsored trials related to this indication."

  • 14

    Aug

ANAB AnaptysBio
$78.32

3.15 (4.19%)

04/04/18
RBCM
04/04/18
DOWNGRADE
Target $86
RBCM
Sector Perform
AnaptysBio downgraded to Sector Perform at RBC Capital on ANB020 uncertainty
As reported earlier, RBC Capital analyst Kennen MacKay downgraded AnaptysBio to Sector Perform from Outperform and lowered his price target to $86 from $144. MacKay cites "increasing skepticism regarding ANB020's path forward in peanut allergy" as post-data credibility concerns create an unfavorable risk-reward going into the company's phase 2a asthma readout expected in Q3. While the analyst expects the ANB020 readout to show a benefit vs. placebo, the results may be "challenging to interpret" relative to the treatment's competition.
05/29/18
JMPS
05/29/18
NO CHANGE
JMPS
JMP says AnaptysBio weakness ahead of asthma read-out a buying opportunity
After Aimmune Therapeutics (AIMT) presented new results from its Phase 3 trial of AR101 in peanut allergy at a medical congress, JMP Securities analyst Konstantinos Aprilakis noted that shares of competitor AnaptysBio (ANAB) are off about 42% over the last three months. He remains a buyer of AnaptysBio on any weakness going into the top-line proof of concept data from the Phase 2a trial of ANB020 in eosinophilic asthma, which is expected in Q3. The analyst, who reminds investors that he assigns about $61/share for the eosinophilic asthma indication in his valuation of AnaptysBio, maintains an Outperform rating and $180 price target on AnaptysBio shares, which closed Friday at $77.90.
07/09/18
JEFF
07/09/18
NO CHANGE
Target $145
JEFF
Buy
AnaptysBio can rally up to $30 on upcoming asthma data, says Jefferies
Jefferies analyst Biren Amin previews this quarter's readout of AnaptysBio's Phase IIa study testing ANB020 in severe asthma. The analyst's analysis suggests most biologics deliver 6%-9% improvement in lung function. A 7%-8% improvement likely drives $15-$20 of share upside while 9%-10% likely pushes the stock up $25-$30, Amin tells investors in a research note. He believes a the lower range of a 5%-6% improvement could trigger a selloff of $10-$15 per share and a true miss of less than 5% improvement could see the stock down $20-$25. He keeps a Buy rating on AnaptysBio with a $145 price target.
07/19/18
FBCO
07/19/18
INITIATION
Target $104
FBCO
Outperform
AnaptysBio initiated with an Outperform at Credit Suisse
Credit Suisse initiated AnaptysBio with an Outperform and $104 price target.

TODAY'S FREE FLY STORIES

IEA

Infrastructure and Energy Alternatives

$8.93

0.45 (5.31%)

12:11
11/14/18
11/14
12:11
11/14/18
12:11
Conference/Events
Infrastructure and Energy Alternatives management to meet with Raymond James »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Dec

VST

Vistra Energy

$23.86

-0.46 (-1.89%)

, EGN

Energen

$70.25

1.13 (1.63%)

12:11
11/14/18
11/14
12:11
11/14/18
12:11
Hot Stocks
Breaking Hot Stocks news story on Vistra Energy, Energen, CenturyLink »

Paulson & Co. exits…

VST

Vistra Energy

$23.86

-0.46 (-1.89%)

EGN

Energen

$70.25

1.13 (1.63%)

CTL

CenturyLink

$18.80

0.02 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVMT

Dell Technologies

$101.23

-0.39 (-0.38%)

12:10
11/14/18
11/14
12:10
11/14/18
12:10
Periodicals
Breaking Periodicals news story on Dell Technologies »

Dell to boost cash…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

KMPR

Kemper

$74.04

-1.31 (-1.74%)

12:10
11/14/18
11/14
12:10
11/14/18
12:10
Conference/Events
Kemper management to meet with Raymond James »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

  • 04

    Dec

NLSN

Nielsen

$26.04

-0.5 (-1.88%)

, DNB

Dun & Bradstreet

$141.85

0.04 (0.03%)

12:10
11/14/18
11/14
12:10
11/14/18
12:10
Hot Stocks
Breaking Hot Stocks news story on Nielsen, Dun & Bradstreet »

Paulson & Co. takes…

NLSN

Nielsen

$26.04

-0.5 (-1.88%)

DNB

Dun & Bradstreet

$141.85

0.04 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRH

CRH

$29.15

0.2 (0.69%)

12:09
11/14/18
11/14
12:09
11/14/18
12:09
Downgrade
CRH rating change  »

CRH downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBUU

Malibu Boats

$49.32

0.55 (1.13%)

12:08
11/14/18
11/14
12:08
11/14/18
12:08
Conference/Events
Malibu Boats management to meet with Raymond James »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

PRA

ProAssurance

$43.45

-0.32 (-0.73%)

12:07
11/14/18
11/14
12:07
11/14/18
12:07
Conference/Events
ProAssurance management to meet with Raymond James »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

SBCF

Seacoast Banking

$25.90

-0.28 (-1.07%)

12:06
11/14/18
11/14
12:06
11/14/18
12:06
Conference/Events
Seacoast Banking management to meet with Raymond James »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

12:05
11/14/18
11/14
12:05
11/14/18
12:05
General news
Euro$ interest rate futures are motoring higher »

Euro$ interest rate…

SQ

Square

$69.43

-2.38 (-3.31%)

12:02
11/14/18
11/14
12:02
11/14/18
12:02
Hot Stocks
Square Payroll introduces benefits offerings for small businesses »

Square announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 12

    Dec

  • 18

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$270.68

-1.32 (-0.49%)

12:02
11/14/18
11/14
12:02
11/14/18
12:02
Periodicals
More than a dozen news groups back CNN suit against White House, Hill says »

Thirteen media…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$270.68

-1.32 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$7.49

-1.775 (-19.16%)

12:00
11/14/18
11/14
12:00
11/14/18
12:00
Hot Stocks
Switch falls -19.1% »

Switch is down -19.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$25.05

-7.65 (-23.39%)

12:00
11/14/18
11/14
12:00
11/14/18
12:00
Hot Stocks
PG&E falls -23.2% »

PG&E is down -23.2%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIG

Transocean

$9.50

0.07 (0.74%)

12:00
11/14/18
11/14
12:00
11/14/18
12:00
Options
10K May 9 puts trade in Transocean options as shares trade up 7c to $9.50 »

10K May 9 puts trade in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$4.49

-1.96 (-30.39%)

12:00
11/14/18
11/14
12:00
11/14/18
12:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN falls -30.4% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVIA

Covia

$6.78

0.955 (16.39%)

12:00
11/14/18
11/14
12:00
11/14/18
12:00
Hot Stocks
Covia rises 17.1% »

Covia is up 17.1%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

UGAZ

VelocityShares 3x Long Natural Gas ETN

$210.20

51.5 (32.45%)

12:00
11/14/18
11/14
12:00
11/14/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 32.8% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAHO

Tahoe Resources

$3.21

1.015 (46.24%)

12:00
11/14/18
11/14
12:00
11/14/18
12:00
Hot Stocks
Tahoe Resources rises 45.9% »

Tahoe Resources is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

M

Macy's

$34.78

-0.99 (-2.77%)

, PCG

PG&E

$25.20

-7.5 (-22.94%)

11:58
11/14/18
11/14
11:58
11/14/18
11:58
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened sharply…

M

Macy's

$34.78

-0.99 (-2.77%)

PCG

PG&E

$25.20

-7.5 (-22.94%)

CGC

Canopy Growth

$34.33

-4.14 (-10.76%)

TLRY

Tilray

$101.50

-9.75 (-8.76%)

TAHO

Tahoe Resources

$3.22

1.025 (46.70%)

PAAS

Pan American Silver

$12.42

-1.71 (-12.10%)

MTSI

Macom

$17.97

2.8 (18.46%)

GOOS

Canada Goose

$67.05

8.45 (14.42%)

SGMO

Sangamo

$9.03

-1.77 (-16.39%)

SWCH

Switch

$7.50

-1.765 (-19.05%)

WIX

Wix.com

$85.93

-5.37 (-5.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

CBTX

CBTX

$33.14

(0.00%)

11:55
11/14/18
11/14
11:55
11/14/18
11:55
Conference/Events
CBTX management to meet with Stephens »

Group Luncheon Meeting to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

MYGN

Myriad Genetics

$29.35

-0.63 (-2.10%)

11:55
11/14/18
11/14
11:55
11/14/18
11:55
Conference/Events
Myriad Genetics management to meet with William Blair »

Group Luncheon Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 03

    Dec

KBR

KBR

$19.16

-0.3 (-1.54%)

11:52
11/14/18
11/14
11:52
11/14/18
11:52
Options
Second day of put buying in KBR »

Second day of put buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$26.13

0.39 (1.52%)

11:51
11/14/18
11/14
11:51
11/14/18
11:51
Conference/Events
MGM Resorts management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 19

    Nov

S

Sprint

$6.14

-0.07 (-1.13%)

, TMUS

T-Mobile

$67.86

-0.59 (-0.86%)

11:50
11/14/18
11/14
11:50
11/14/18
11:50
Hot Stocks
THE FCC commences auction of first block of mmWave 5G spectrum »

The Federal…

S

Sprint

$6.14

-0.07 (-1.13%)

TMUS

T-Mobile

$67.86

-0.59 (-0.86%)

VZ

Verizon

$58.46

-0.21 (-0.36%)

USM

U.S. Cellular

$53.82

-0.09 (-0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 26

    Nov

  • 04

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.